Inditex achieves historic results in the first half of 2022 despite the current economic situation marked by the war in Ukraine and inflation. The parent company of Zara, Berskha, or Stradivarius, achieves historic sales, Ebitda, and profit figures.
The company chaired by Marta Ortega earned 41% more than in the same period of 2021, up to €1.8 million and sales reached €14.85 million, with growth at a constant rate of 25%.
Read more about Inditex and find the most important business news from around the world with the Born2Invest mobile app.
Net cash also rose 15% to €9.24 million
“These results are explained by four key factors in our performance. Our fashion proposition, a constantly optimized shopping experience for our customers, our focus on sustainability, and the talent and commitment of our people,” said CEO Óscar García Maceiras.
In addition, the gross margin of the also owner of Pull&Bear or Massimo Dutti stood at €8.6 million, 24.5% higher than in the first half of 2021, and represents 57.9% of sales, the highest in the last 7 years. Operating income (EBITDA) rose by 30% to €4.03 million and operating expenses grew by 20% compared to the first half of 2021, below the growth in sales.
Net cash also rose 15% to €9.24 million. For its part, online sales progressed “satisfactorily” and were positive in the second quarter. As a result, it maintains its forecast that it will exceed 30% of total sales by 2024. “Our business model is working at full capacity and has great potential for future growth,” added Maceiras.
Meanwhile, in-store and online sales at constant exchange rates between August 1st and September 11th, 2022 grew 11% over the record 2021 period. During its fiscal first quarter, it made openings in 24 markets and has 6,370 stores spread around the world.
Inditex’s supply chain
To address potential supply chain stresses and ensure product availability during the second half of 2022, the company has temporarily brought forward inventory inflows for the fall/winter season. As a result, inventory on July 31st, 2022 grew by 43%.
In addition, the company said it has fully provisioned for estimated expenses for the 2022 fiscal year in the Russian Federation and Ukraine. An extraordinary charge of €216 million was already included in the first-quarter accounts.
The company has also informed the Spanish Securities and Exchange Commission (CNMV) that the final dividend for 2021 (€0.465 per share) will be paid on November 2nd, 2022, and will publish the results for the first nine months of 2022 on December 14th.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in EL INDEPENDIENTE, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Audax, a Low-Risk ESG Company According to Morningstar Sustainalytics ESG Rating
In summary, Audax has demonstrated its leadership in sustainability and ESG performance by earning an "ESG Low-Risk Company" rating from...
VR Bank Bamberg-Forchheim Celebrates Seven Successful Crowdfunding Projects
The VR Bank Bamberg-Forchheim eG not only initiates and maintains the online platform, but also acts as a donor. Because...
Alarming Campaign Absenteeism Jeopardizes Bill Regulating Recreational Cannabis in Colombia
The bill regulating recreational cannabis must pass a total of eight debates, divided into first and second rounds: four and...
CNBV Calls for Unity in the Mexican Fintech Sector to Drive its Development
The fintech sector is made up of 650 identified firms, according to the latest Fintech Radar Mexico 2023 published by...
Jazz Pharmaceuticals’ Leukemia Drug Receives European Commission Approval
Jazz Pharmaceuticals is a biopharmaceutical company dedicated to the development of drugs in neuroscience and oncology. Founded in 2003 in...
Biotech2 weeks ago
Asabys Partners Leads a €14 Million Round in Gradient Denervation
Crowdfunding3 days ago
GoodNews Launches a Crowdfunding Campaign on Crowdcube
Biotech1 week ago
Vertex Obtains EMA Validation to Expand Indications for Kaftrio
Biotech7 days ago
Novo Nordisk Plans to Open a Tech Headquarters in Spain